|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.065 USD | -3.44% |
|
-10.00% | -32.39% |
BioCryst Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was USD 157.17 million compared to USD 17.81 million a year ago. Net loss was USD 184.06 million compared to USD 182.81 million a year ago.
Basic loss per share from continuing operations was USD 1.03 compared to USD 1.09 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -32.39% | 868M | |
| -2.20% | 104B | |
| +1.49% | 97.42B | |
| +0.79% | 22.2B | |
| -18.06% | 21.23B | |
| -11.11% | 18.33B | |
| -42.83% | 16.35B | |
| -16.16% | 15.06B | |
| +4.14% | 13.98B | |
| +34.74% | 11.66B |
BIOCRYST PHARMACEUTICALS, INC. 
